FDA recall D-0896-2023

Vivus, Inc. · Class III · drug

Product

PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,

Reason for recall

Failed Stability Specifications

Distribution

Nationwide within the United States

Key facts

Status
Ongoing
Initiation date
2023-06-23
Report date
2023-07-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Campbell, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0896-2023